An efficacy and safety comparison study of Fenofibrate and omega 3 in pediatric patients with Hypertriglyceridemia, A Randomized Clinical Trial

Phase 2

Recruiting

• Conditions: Hypertriglyceridemia.; Pure hyperglyceridemia, Endogenous hyperglyceridemia; E78.1

• Registration Number: IRCT20220516054879N4
• Lead Sponsor: Rasht University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

8-12 years old Patients with hypertriglyceridemia, with triglyceride more than 400mg/dl or triglyceride more than 250mg/dl that are intended to use medication or not responded to diet and exercise.

Exclusion Criteria

Patient reluctance
Patient treated with statins or ezetimibe
Pragnancy
Acute or chronic pancreatitis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting blood triglycerides. Timepoint: The variable will be measured at the beginning of the study, 8 and 12 weeks after the start of the study. Method of measurement: Blood tests.;Fasting blood LDL level. Timepoint: The variable will be measured at the beginning of the study, 8 and 12 weeks after the start of the study. Method of measurement: Blood tests.;Fasting blood cholesterol. Timepoint: The variable will be measured at the beginning of the study, 8 and 12 weeks after the start of the study. Method of measurement: Blood tests.